Influenza Diagnostic Market Report 2026
Download Free Sample Buy Now
Influenza Diagnostic Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Influenza Diagnostic Market Report 2026

Global Outlook – By Traditional Diagnostic Tests (Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests ), By Molecular Diagnostic Tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests ), By End User (Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Influenza Diagnostic Market Overview

• Influenza Diagnostic market size has reached to $2.87 billion in 2025

• Expected to grow to $4.19 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: Increased Research Funding Boosts Influenza Diagnostics

• Market Trend: Innovative Products In Influenza Diagnostic Market Development

• North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Influenza Diagnostic Market?

Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection.

The main traditional diagnostic test types of influenza diagnostics are rapid influenza diagnostic tests (RIDT), viral culture, DFA, serological assays and others. Rapid influenza diagnostic tests (RIDTs) are immunoassays that can detect the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and provide a qualitative result (positive vs. negative). The various molecular diagnostic tests include Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), loop mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, other isothermal nucleic acid amplification tests and are used by hospitals and clinical laboratories, diagnostic reference laboratories, academic/research institutes, other end users.

Influenza Diagnostic Market Global Report 2026 Market Report bar graph

What Is The Influenza Diagnostic Market Size and Share 2026?

The influenza diagnostic market size has grown strongly in recent years. It will grow from $2.87 billion in 2025 to $3.1 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to seasonal influenza outbreaks, widespread use of rapid antigen tests, growth of hospital laboratory infrastructure, government influenza surveillance programs, increased awareness of early flu diagnosis.

What Is The Influenza Diagnostic Market Growth Forecast?

The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $4.19 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising frequency of influenza epidemics, growing demand for accurate molecular diagnostics, expansion of point-of-care testing facilities, increased public health preparedness initiatives, technological advancements in rapid diagnostic assays. Major trends in the forecast period include rising demand for rapid influenza testing, increased adoption of molecular diagnostic methods, growing preference for point-of-care flu diagnostics, expansion of seasonal and pandemic surveillance testing, continuous improvement in test sensitivity and specificity.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Influenza Diagnostic Market Segmentation

1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests

2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

Subsegments:

1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

2) By Viral Culture: Cell Culture, Egg-based Culture

3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

What Is The Driver Of The Influenza Diagnostic Market?

The increasing funding for research on influenza diagnostics is expected to propel the growth of the influenza diagnostic market going forward. Funding for research on influenza diagnostics refers to financial resources allocated by government agencies, institutions, and organizations to support scientific investigations aimed at developing, improving, and validating methods and technologies for detecting and identifying influenza viruses. The rising funding for influenza research is driven by lessons learned from the COVID-19 pandemic and concerns about future respiratory disease outbreaks, as health authorities recognize the critical importance of rapid and accurate diagnostic capabilities to prevent widespread transmission and enable timely public health interventions. Growing research funding supports the development and commercialization of advanced testing technologies, molecular assays, point-of-care devices, and improved laboratory procedures that enable faster and more accurate identification of influenza strains in clinical settings. For instance, in October 2024, according to the Department of Health and Aged Care, a Australia-based government organization responsible for health research, funding, promotion and regulation, the Australian Government is allocating $95 million to combat avian influenza, protecting agriculture, wildlife, and the economy. Therefore, increasing funding for research on influenza diagnostics is driving the growth of the influenza diagnostic industry.

Key Players In The Global Influenza Diagnostic Market

Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.

Global Influenza Diagnostic Market Trends and Insights

Major companies operating in the influenza diagnostic market are developing innovative products such as Lucira COVID-19 & Flu Home Test for the simultaneous rapid qualitative detection. The Lucira COVID-19 and Flu Home Test is a single-use at-home test kit that provides results from self-collected nasal swab samples in roughly 30 minutes. For instance, in February 2023, Pfizer Inc., a US-based pharmaceutical company received approval for the Lucira COVID-19 & Flu Home Test. The test can detect influenza A and B, commonly known as the flu, and SARS-CoV-2, the virus that causes COVID-19.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Influenza Diagnostic Market?

In February 2024, Thyrocare Technologies Limited, a India-based healthcare company, acquired Think Health Diagnostic Private Limited for an undisclosed amount. This acquisition enhances Thyrocare’s service offerings, allowing them to reach more customers and improve market share in the diagnostic sector. Additionally, by integrating at-home ECG testing with blood diagnostics, thereby positioning itself as a comprehensive solution for premedical and annual health checkups. Think Health Diagnostic Private Limited is a India-based home health care services company specializes in providing serves such as telehealth, laboratory testing, and pharmacy.

Regional Outlook

North America was the largest region in the influenza diagnostics market in 2025. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Influenza Diagnostic Market?

The influenza diagnostic market includes revenue earned by test kit and reagents, and other products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Influenza Diagnostic Market Report 2026?

The influenza diagnostic market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the influenza diagnostic industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Influenza Diagnostic Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.1 billion
Revenue Forecast In 2035 $4.19 billion
Growth Rate CAGR of 8.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Traditional Diagnostic Tests, Molecular Diagnostic Tests, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Influenza Diagnostic Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Influenza Diagnostic Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Influenza Diagnostic Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Influenza Diagnostic Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Demand For Rapid Influenza Testing

4.2.2 Increased Adoption Of Molecular Diagnostic Methods

4.2.3 Growing Preference For Point-Of-Care Flu Diagnostics

4.2.4 Expansion Of Seasonal And Pandemic Surveillance Testing

4.2.5 Continuous Improvement In Test Sensitivity And Specificity

5. Influenza Diagnostic Market Analysis Of End Use Industries

5.1 Hospitals And Clinical Laboratories

5.2 Diagnostic Reference Laboratories

5.3 Academic And Research Institutes

5.4 Public Health Laboratories

5.5 Point-Of-Care Testing Centers

6. Influenza Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Influenza Diagnostic Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Influenza Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Influenza Diagnostic Market Size, Comparisons And Growth Rate Analysis

7.3. Global Influenza Diagnostic Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Influenza Diagnostic Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Influenza Diagnostic Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Influenza Diagnostic Market Segmentation

9.1. Global Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, Serological Assays, Other Traditional Diagnostic Tests

9.2. Global Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

9.3. Global Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

9.4. Global Influenza Diagnostic Market, Sub-Segmentation Of Rapid Influenza Diagnostic Tests (RIDT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

9.5. Global Influenza Diagnostic Market, Sub-Segmentation Of Viral Culture, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cell Culture, Egg-based Culture

9.6. Global Influenza Diagnostic Market, Sub-Segmentation Of Serological Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

9.7. Global Influenza Diagnostic Market, Sub-Segmentation Of Other Traditional Diagnostic Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR), Immunofluorescence Assays

10. Influenza Diagnostic Market Regional And Country Analysis

10.1. Global Influenza Diagnostic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Influenza Diagnostic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Influenza Diagnostic Market

11.1. Asia-Pacific Influenza Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Influenza Diagnostic Market

12.1. China Influenza Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Influenza Diagnostic Market

13.1. India Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Influenza Diagnostic Market

14.1. Japan Influenza Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Influenza Diagnostic Market

15.1. Australia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Influenza Diagnostic Market

16.1. Indonesia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Influenza Diagnostic Market

17.1. South Korea Influenza Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Influenza Diagnostic Market

18.1. Taiwan Influenza Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Influenza Diagnostic Market

19.1. South East Asia Influenza Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Influenza Diagnostic Market

20.1. Western Europe Influenza Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Influenza Diagnostic Market

21.1. UK Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Influenza Diagnostic Market

22.1. Germany Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Influenza Diagnostic Market

23.1. France Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Influenza Diagnostic Market

24.1. Italy Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Influenza Diagnostic Market

25.1. Spain Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Influenza Diagnostic Market

26.1. Eastern Europe Influenza Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Influenza Diagnostic Market

27.1. Russia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Influenza Diagnostic Market

28.1. North America Influenza Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Influenza Diagnostic Market

29.1. USA Influenza Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Influenza Diagnostic Market

30.1. Canada Influenza Diagnostic Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Influenza Diagnostic Market

31.1. South America Influenza Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Influenza Diagnostic Market

32.1. Brazil Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Influenza Diagnostic Market

33.1. Middle East Influenza Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Influenza Diagnostic Market

34.1. Africa Influenza Diagnostic Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Segmentation By Molecular Diagnostic Tests, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Influenza Diagnostic Market Regulatory and Investment Landscape

36. Influenza Diagnostic Market Competitive Landscape And Company Profiles

36.1. Influenza Diagnostic Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Influenza Diagnostic Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Influenza Diagnostic Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Influenza Diagnostic Market Other Major And Innovative Companies

Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH

38. Global Influenza Diagnostic Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Influenza Diagnostic Market

40. Influenza Diagnostic Market High Potential Countries, Segments and Strategies

40.1 Influenza Diagnostic Market In 2030 - Countries Offering Most New Opportunities

40.2 Influenza Diagnostic Market In 2030 - Segments Offering Most New Opportunities

40.3 Influenza Diagnostic Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Influenza Diagnostic Market, Overview Of Key Products - Product Examples
  • Table 2: Global Influenza Diagnostic Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Influenza Diagnostic Market, Supply Chain Analysis
  • Table 4: Global Influenza Diagnostic Market, Major Raw Material Providers
  • Table 5: Global Influenza Diagnostic Market, Major Resource Providers
  • Table 6: Global Influenza Diagnostic Market, Major Manufacturers (Suppliers)
  • Table 7: Global Influenza Diagnostic Market, Major Distributors And Channel Partners
  • Table 8: Global Influenza Diagnostic Market, Key Technologies & Future Trends
  • Table 9: Global Influenza Diagnostic Market, Major Trends
  • Table 10: Global Influenza Diagnostic Market, Major End Users
  • Table 11: Global Influenza Diagnostic Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Influenza Diagnostic Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Influenza Diagnostic Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Influenza Diagnostic Market - TAM, US$ Billion, 2025
  • Table 15: Global Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Influenza Diagnostic Market, Sub-Segmentation Of Rapid Influenza Diagnostic Tests (RIDT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Influenza Diagnostic Market, Sub-Segmentation Of Viral Culture, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Influenza Diagnostic Market, Sub-Segmentation Of Serological Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Influenza Diagnostic Market, Sub-Segmentation Of Other Traditional Diagnostic Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Influenza Diagnostic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Influenza Diagnostic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Influenza Diagnostic Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Influenza Diagnostic Market - Company Scoring Matrix
  • Table 98: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 99: Quidel Corporation Financial Performance
  • Table 100: Thermo Fisher Scientific Inc. Financial Performance
  • Table 101: Abbott Laboratories Financial Performance
  • Table 102: Hologic Inc. Financial Performance
  • Table 103: Global Influenza Diagnostic Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Influenza Diagnostic Market, Competitive Dashboard
  • Table 105: Global Influenza Diagnostic Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Influenza Diagnostic Market Size Gain ($ Billion), Segmentation By Traditional Diagnostic Tests, 2025 – 2030
  • Table 107: Global, Influenza Diagnostic Market Size Gain ($ Billion), Segmentation By Molecular Diagnostic Tests, 2025 – 2030
  • Table 108: Global, Influenza Diagnostic Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Influenza Diagnostic Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Influenza Diagnostic Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Influenza Diagnostic Market, Supply Chain Analysis
  • Figure 4: Global Influenza Diagnostic Market, Major Raw Material Providers
  • Figure 5: Global Influenza Diagnostic Market, Major Resource Providers
  • Figure 6: Global Influenza Diagnostic Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Influenza Diagnostic Market, Major Distributors And Channel Partners
  • Figure 8: Global Influenza Diagnostic Market, Key Technologies & Future Trends
  • Figure 9: Global Influenza Diagnostic Market, Major Trends
  • Figure 10: Global Influenza Diagnostic Market, Major End Users
  • Figure 11: Global Influenza Diagnostic Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Influenza Diagnostic Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Influenza Diagnostic Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Influenza Diagnostic Market - TAM, US$ Billion, 2025
  • Figure 15: Global Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Influenza Diagnostic Market, Sub-Segmentation Of Rapid Influenza Diagnostic Tests (RIDT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Influenza Diagnostic Market, Sub-Segmentation Of Viral Culture, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Influenza Diagnostic Market, Sub-Segmentation Of Serological Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Influenza Diagnostic Market, Sub-Segmentation Of Other Traditional Diagnostic Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Influenza Diagnostic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Influenza Diagnostic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Influenza Diagnostic Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Influenza Diagnostic Market - Company Scoring Matrix
  • Figure 98: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 99: Quidel Corporation Financial Performance
  • Figure 100: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 101: Abbott Laboratories Financial Performance
  • Figure 102: Hologic Inc. Financial Performance
  • Figure 103: Global Influenza Diagnostic Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Influenza Diagnostic Market, Competitive Dashboard
  • Figure 105: Global Influenza Diagnostic Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Influenza Diagnostic Market Size Gain ($ Billion), Segmentation By Traditional Diagnostic Tests, 2025 – 2030
  • Figure 107: Global, Influenza Diagnostic Market Size Gain ($ Billion), Segmentation By Molecular Diagnostic Tests, 2025 – 2030
  • Figure 108: Global, Influenza Diagnostic Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Read More About Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Influenza Diagnostic Market Report 2026 - Global Outlook – By Traditional Diagnostic Tests (Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests ), By Molecu...

Behavioral Rehabilitation Market Report 2026 - Global Outlook – By Treatment Method (Counseling, Medication, Support Services, Other Treatment Methods), By Application (Anxiety Disorders, Mood Disorders, Substance Abuse ...

Alcohol Excipients Market Report 2026 - Global Outlook – By Type (Sorbitol, Mannitol, Propylene Glycol, Glycerin, Other Types), By Application (Pharmaceutical, Personal Care, Cosmetics, Other Applications), By Distributi...

Aircraft Sensors Market Report 2026 - Global Outlook – By Sensor Type (Temperature, Pressure, Position, Flow, Torque, Radar, Accelerometer, Proximity), By Aircraft Type (Narrow-Body Aircraft, Wide-Body Aircraft, Very Lar...

Allogeneic T Cell Therapies Market Report 2026 - Global Outlook – By Product Type (Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies), By Antigen Type (CD 19, CD 20, Egfrvlll, GD2, CD22, C...

High Flow Needle Sets Market Report 2026 - Global Outlook – By Product Type (High Flow Needle Sets, High Flow Winged (Butterfly) Needle Sets, High Flow Safety Needle Sets), By Gauge Size (18 Gauge High Flow Needle Sets, ...

Virtual Data Room Global Market Report 2025 – By Component (Solution, Services), By Deployment Type (Cloud Based, On Premise), By Organization Size (Small- and Medium-scale Organizations, Large Organizations), By Vertica...

Frequently Asked Questions

The Influenza Diagnostic Market Report 2026 market was valued at $2.87 billion in 2025, increased to $3.1 billion in 2026, and is projected to reach $4.19 billion by 2030. request a sample here

The expected CAGR for the Influenza Diagnostic Market Report 2026 market during the forecast period 2025–2030 is 7.8%. request a sample here

Major growth driver of the market includes: Increased Research Funding Boosts Influenza Diagnostics in the Influenza Diagnostic Market Report 2026 market. For further insights on this market, request a sample here

The influenza diagnostic market covered in this report is segmented –
1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests
2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users Subsegments:
1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)
2) By Viral Culture: Cell Culture, Egg-based Culture
3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay
4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays request a sample here

Major trend in this market includes: Innovative Products In Influenza Diagnostic Market Development For further insights on this market, request a sample here.

Major companies operating in the Influenza Diagnostic Market Report 2026 market are Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc. request a sample here.

North America was the largest region in the influenza diagnostics market in 2025. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us